Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 204

1.

An update on chronic kidney disease in Aboriginal Australians.

Hoy WE, Mott SA, McDonald SP.

Clin Nephrol. 2019 Aug 20. doi: 10.5414/CNP92S122. [Epub ahead of print]

PMID:
31426912
2.

Considerable international variation exists in blood pressure control and antihypertensive prescription patterns in chronic kidney disease.

Alencar de Pinho N, Levin A, Fukagawa M, Hoy WE, Pecoits-Filho R, Reichel H, Robinson B, Kitiyakara C, Wang J, Eckardt KU, Jha V, Oh KH, Sola L, Eder S, de Borst M, Taal M, Feldman HI, Stengel B; International Network of Chronic Kidney Disease cohort studies (iNET-CKD).

Kidney Int. 2019 Jul 25. pii: S0085-2538(19)30512-5. doi: 10.1016/j.kint.2019.04.032. [Epub ahead of print]

PMID:
31358344
3.

Heavy metal imaging in fibrotic human kidney tissue using the synchrotron X-ray fluorescence microprobe.

Gobe GC, Mott SA, de Jonge M, Hoy WE.

Transl Androl Urol. 2019 May;8(Suppl 2):S184-S191. doi: 10.21037/tau.2019.03.15. Review.

4.

Biomarkers and the role of mast cells as facilitators of inflammation and fibrosis in chronic kidney disease.

Owens EP, Vesey DA, Kassianos AJ, Healy H, Hoy WE, Gobe GC.

Transl Androl Urol. 2019 May;8(Suppl 2):S175-S183. doi: 10.21037/tau.2018.11.03. Review.

5.

A randomised controlled trial of potential for pharmacologic prevention of new-onset albuminuria, hypertension and diabetes in a remote Aboriginal Australian community, 2008-2013.

Hoy WE, Reid CM, Huq M, McLeod BJ, Mott SA.

Contemp Clin Trials Commun. 2019 Jan 14;14:100323. doi: 10.1016/j.conctc.2019.100323. eCollection 2019 Jun.

6.

Chronic kidney disease, Queensland: Profile of patients with chronic kidney disease from regional Queensland, Australia: A registry report.

Venuthurupalli SK, Healy H, Fassett R, Cameron A, Wang Z, Hoy WE.

Nephrology (Carlton). 2019 Jan 20. doi: 10.1111/nep.13567. [Epub ahead of print]

PMID:
30663166
7.

Biopsy-based estimation of total nephron number in Japanese living kidney donors.

Sasaki T, Tsuboi N, Kanzaki G, Haruhara K, Okabayashi Y, Koike K, Kobayashi A, Yamamoto I, Ogura M, Hoy WE, Bertram JF, Shimizu A, Yokoo T.

Clin Exp Nephrol. 2019 May;23(5):629-637. doi: 10.1007/s10157-018-01686-2. Epub 2019 Jan 12.

PMID:
30635748
8.

Chronic Kidney Disease, Queensland (CKD.QLD) Registry: Management of CKD With Telenephrology.

Venuthurupalli SK, Rolfe A, Fanning J, Cameron A, Hoy WE; NHMRC CKD.CRE and the CKD.QLD Collaborative.

Kidney Int Rep. 2018 Jul 21;3(6):1336-1343. doi: 10.1016/j.ekir.2018.07.013. eCollection 2018 Nov.

9.

Body mass index in an Australian population with chronic kidney disease.

Chan S, Cameron A, Wang Z, Venuthurupalli SK, Tan KS, Healy HG, Hoy WE.

BMC Nephrol. 2018 Aug 20;19(1):209. doi: 10.1186/s12882-018-1006-2.

10.

Health service utilisation during the last year of life: a prospective, longitudinal study of the pathways of patients with chronic kidney disease stages 3-5.

Chambers S, Healy H, Hoy WE, Kark A, Ratanjee S, Mitchell G, Douglas C, Yates P, Bonner A.

BMC Palliat Care. 2018 Apr 5;17(1):57. doi: 10.1186/s12904-018-0310-8.

11.

Chronic kidney disease mortality trends in selected Central America countries, 1997-2013: clues to an epidemic of chronic interstitial nephritis of agricultural communities.

Ordunez P, Nieto FJ, Martinez R, Soliz P, Giraldo GP, Mott SA, Hoy WE.

J Epidemiol Community Health. 2018 Apr;72(4):280-286. doi: 10.1136/jech-2017-210023. Epub 2018 Feb 2.

PMID:
29437864
12.

Case definitions and approaches for surveillance of chronic kidney disease in agricultural communities in Central America: policy implications.

Ordunez P, Hoy WE.

Kidney Int. 2018 Feb;93(2):284-287. doi: 10.1016/j.kint.2017.10.029. No abstract available.

13.

High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.

Barr ELM, Barzi F, Hughes JT, Jerums G, Hoy WE, O'Dea K, Jones GRD, Lawton PD, Brown ADH, Thomas M, Ekinci EI, Sinha A, Cass A, MacIsaac RJ, Maple-Brown LJ.

Diabetes Care. 2018 Apr;41(4):739-747. doi: 10.2337/dc17-1919. Epub 2018 Jan 24.

PMID:
29367427
14.

The Barker hypothesis confirmed: association of low birth weight with all-cause natural deaths in young adult life in a remote Australian Aboriginal community.

Hoy WE, Nicol JL.

J Dev Orig Health Dis. 2019 Feb;10(1):55-62. doi: 10.1017/S2040174417000903. Epub 2018 Jan 25.

PMID:
29366439
15.

APOL1 Risk Variants Independently Associated With Early Cardiovascular Disease Death.

Hughson MD, Hoy WE, Mott SA, Bertram JF, Winkler CA, Kopp JB.

Kidney Int Rep. 2017 Aug 24;3(1):89-98. doi: 10.1016/j.ekir.2017.08.007. eCollection 2018 Jan.

16.

CKD Screening and Surveillance in Australia: Past, Present, and Future.

Venuthurupalli SK, Hoy WE, Healy HG, Cameron A, Fassett RG.

Kidney Int Rep. 2017 Oct 6;3(1):36-46. doi: 10.1016/j.ekir.2017.09.012. eCollection 2018 Jan. Review.

17.

Spectrum (characteristics) of patients with chronic kidney disease (CKD) with increasing age in a major metropolitan renal service.

Mahmood U, Healy HG, Kark A, Cameron A, Wang Z, Abeysekera R, Hoy WE.

BMC Nephrol. 2017 Dec 28;18(1):372. doi: 10.1186/s12882-017-0781-5.

18.

Cross-sectional associations of albuminuria among Aboriginal and Torres Strait Islander adults: the eGFR Study.

Hughes JT, Maple-Brown LJ, Thomas M, Lawton PD, Sinha A, Cass A, Barzi F, Jones G, Jerums G, MacIsaac RJ, O'Dea K, Hoy WE.

Nephrology (Carlton). 2018 Jan;23(1):37-45. doi: 10.1111/nep.12956.

PMID:
29250918
19.

New insights on glomerular hyperfiltration: a Japanese autopsy study.

Kanzaki G, Puelles VG, Cullen-McEwen LA, Hoy WE, Okabayashi Y, Tsuboi N, Shimizu A, Denton KM, Hughson MD, Yokoo T, Bertram JF.

JCI Insight. 2017 Oct 5;2(19). pii: 94334. doi: 10.1172/jci.insight.94334.

20.

Bilirubin concentration is positively associated with haemoglobin concentration and inversely associated with albumin to creatinine ratio among Indigenous Australians: eGFR Study.

Hughes JT, Barzi F, Hoy WE, Jones GRD, Rathnayake G, Majoni SW, Thomas MAB, Sinha A, Cass A, MacIsaac RJ, O'Dea K, Maple-Brown LJ.

Clin Biochem. 2017 Dec;50(18):1040-1047. doi: 10.1016/j.clinbiochem.2017.08.011. Epub 2017 Aug 20.

PMID:
28834701
21.

Transformation of mortality in a remote Australian Aboriginal community: a retrospective observational study.

Hoy WE, Mott SA, McLeod BJ.

BMJ Open. 2017 Aug 11;7(8):e016094. doi: 10.1136/bmjopen-2017-016094.

22.

Follow-up reply to Dr Paul Lawton's "A response to an expanded nationwide view of chronic kidney disease in Aboriginal Australians, Nephrology, 21 (2016), 916-922".

Hoy WE, Mott SA, McDonald SP.

Nephrology (Carlton). 2017 Jul;22(7):574. doi: 10.1111/nep.13041. No abstract available.

PMID:
28621005
23.

CKD.QLD: establishment of a chronic kidney disease [CKD] registry in Queensland, Australia.

Venuthurupalli SK, Hoy WE, Healy HG, Cameron A, Fassett RG.

BMC Nephrol. 2017 Jun 7;18(1):189. doi: 10.1186/s12882-017-0607-5.

24.

Absence of APOL1 risk alleles in a remote living Australian Aboriginal group with high rates of CKD, hypertension, diabetes, and cardiovascular disease.

Hoy WE, Kopp JB, Mott SA, Winkler CA.

Kidney Int. 2017 Apr;91(4):990. doi: 10.1016/j.kint.2016.11.031. No abstract available.

25.

Kidney disease in hepatitis B surface antigen-positive children: experience from a centre in south-west Nigeria and a review of the Nigerian literature.

Asinobi AO, Ademola AD, Okolo CA, Adepoju AA, Samuel SM, Hoy WE.

Paediatr Int Child Health. 2018 Feb;38(1):16-22. doi: 10.1080/20469047.2016.1251532. Epub 2017 Jan 23. Review.

PMID:
28112049
26.

Comparison of creatinine and cystatin C based eGFR in the estimation of glomerular filtration rate in Indigenous Australians: The eGFR Study.

Barr EL, Maple-Brown LJ, Barzi F, Hughes JT, Jerums G, Ekinci EI, Ellis AG, Jones GR, Lawton PD, Sajiv C, Majoni SW, Brown AD, Hoy WE, O'Dea K, Cass A, MacIsaac RJ.

Clin Biochem. 2017 Apr;50(6):301-308. doi: 10.1016/j.clinbiochem.2016.11.024. Epub 2016 Nov 25.

PMID:
27894952
27.

Familial aggregation of albuminuria and arterial hypertension in an Aboriginal Australian community and the contribution of variants in ACE and TP53.

Duffy DL, McDonald SP, Hayhurst B, Panagiotopoulos S, Smith TJ, Wang XL, Wilcken DE, Duarte NL, Mathews J, Hoy WE.

BMC Nephrol. 2016 Nov 21;17(1):183.

28.

APOL1 Risk Alleles are Associated with More Severe Arteriosclerosis in Renal Resistance Vessels with Aging and Hypertension.

Hughson MD, Hoy WE, Mott SA, Puelles VG, Bertram JF, Winkler CL, Kopp JB.

Kidney Int Rep. 2016 May;1(1):10-23. Epub 2016 Apr 20.

29.

International Network of Chronic Kidney Disease cohort studies (iNET-CKD): a global network of chronic kidney disease cohorts.

Dienemann T, Fujii N, Orlandi P, Nessel L, Furth SL, Hoy WE, Matsuo S, Mayer G, Methven S, Schaefer F, Schaeffner ES, Solá L, Stengel B, Wanner C, Zhang L, Levin A, Eckardt KU, Feldman HI.

BMC Nephrol. 2016 Sep 2;17(1):121. doi: 10.1186/s12882-016-0335-2.

30.

Ageing: Nephron loss in the ageing kidney - it's more than you think.

Bertram JF, Hoy WE.

Nat Rev Nephrol. 2016 Oct;12(10):585-6. doi: 10.1038/nrneph.2016.130. Epub 2016 Aug 30. No abstract available.

PMID:
27573729
31.

Body mass index and waist circumference as predictors of all-cause mortality in an Aboriginal Australian community.

Adegbija O, Hoy WE, Dong B, Wang Z.

Obes Res Clin Pract. 2017 Jan - Feb;11(1):19-26. doi: 10.1016/j.orcp.2016.06.003. Epub 2016 Jun 28.

PMID:
27364234
33.

Progression of Kidney Disease in Indigenous Australians: The eGFR Follow-up Study.

Maple-Brown LJ, Hughes JT, Ritte R, Barzi F, Hoy WE, Lawton PD, Jones GR, Death E, Simmonds A, Sinha AK, Cherian S, Thomas MA, McDermott R, Brown AD, O'Dea K, Jerums G, Cass A, MacIsaac RJ.

Clin J Am Soc Nephrol. 2016 Jun 6;11(6):993-1004. doi: 10.2215/CJN.09770915. Epub 2016 Apr 13.

34.

An expanded nationwide view of chronic kidney disease in Aboriginal Australians.

Hoy WE, Mott SA, Mc Donald SP.

Nephrology (Carlton). 2016 Nov;21(11):916-922. doi: 10.1111/nep.12798. Review. Erratum in: Nephrology (Carlton). 2017 Feb;22(2):185. Nephrology (Carlton). 2018 Jan;23 (1):98.

35.

The Association between HbA1c and Cardiovascular Disease Markers in a Remote Indigenous Australian Community with and without Diagnosed Diabetes.

Arnold LW, Hoy WE, Sharma SK, Wang Z.

J Diabetes Res. 2016;2016:5342304. doi: 10.1155/2016/5342304. Epub 2016 Feb 17.

36.

Human podocyte depletion in association with older age and hypertension.

Puelles VG, Cullen-McEwen LA, Taylor GE, Li J, Hughson MD, Kerr PG, Hoy WE, Bertram JF.

Am J Physiol Renal Physiol. 2016 Apr 1;310(7):F656-F668. doi: 10.1152/ajprenal.00497.2015. Epub 2016 Jan 20.

37.

Associations of serum adiponectin with markers of cardio-metabolic disease risk in Indigenous Australian adults with good health, diabetes and chronic kidney disease.

Hughes JT, O'Dea K, Piera K, Barzi F, Cass A, Hoy WE, MacIsaac RJ, Maple-Brown LJ.

Obes Res Clin Pract. 2016 Nov - Dec;10(6):659-672. doi: 10.1016/j.orcp.2015.11.008. Epub 2015 Dec 5.

PMID:
26669799
39.

Corresponding waist circumference and body mass index values based on 10-year absolute type 2 diabetes risk in an Australian Aboriginal community.

Adegbija O, Hoy WE, Wang Z.

BMJ Open Diabetes Res Care. 2015 Sep 16;3(1):e000127. doi: 10.1136/bmjdrc-2015-000127. eCollection 2015.

40.

A protocol for the identification and validation of novel genetic causes of kidney disease.

Mallett A, Patel C, Maier B, McGaughran J, Gabbett M, Takasato M, Cameron A, Trnka P, Alexander SI, Rangan G, Tchan MC, Caruana G, John G, Quinlan C, McCarthy HJ, Hyland V, Hoy WE, Wolvetang E, Taft R, Simons C, Healy H, Little M.

BMC Nephrol. 2015 Sep 15;16:152. doi: 10.1186/s12882-015-0148-8.

41.

Gestational diabetes and the risk of subsequent Type 2 diabetes in Australian Aboriginal women living in a remote community.

Sina M, Hoy WE, Wang Z.

Diabet Med. 2016 May;33(5):693-4. doi: 10.1111/dme.12892. No abstract available.

PMID:
26308662
42.

APOL1 Risk Alleles Are Associated with Exaggerated Age-Related Changes in Glomerular Number and Volume in African-American Adults: An Autopsy Study.

Hoy WE, Hughson MD, Kopp JB, Mott SA, Bertram JF, Winkler CA.

J Am Soc Nephrol. 2015 Dec;26(12):3179-89. doi: 10.1681/ASN.2014080768. Epub 2015 Jun 2.

43.

Low birth weight and large adult waist circumference increase the risk of cardiovascular disease in remote indigenous Australians--An 18 year cohort study.

Arnold LW, Hoy WE, Wang Z.

Int J Cardiol. 2015;186:273-5. doi: 10.1016/j.ijcard.2015.03.209. Epub 2015 Mar 18. No abstract available.

PMID:
25828133
44.

The associations of anthropometric measurements with subsequent gestational diabetes in Aboriginal women.

Sina M, Hoy WE, Callaway L, Wang Z.

Obes Res Clin Pract. 2015 Sep-Oct;9(5):499-506. doi: 10.1016/j.orcp.2015.02.005. Epub 2015 Mar 19.

PMID:
25797102
46.

Adding measures of body composition to the CKD-EPI GFR estimating equation in Indigenous Australians: the eGFR study.

Maple-Brown LJ, Hughes JT, Chatfield MD, Ward LC, Piers LS, Jones GR, Lawton PD, Ellis AG, Cass A, Hoy WE, O'Dea K, MacIsaac RJ, Jerums G.

Am J Kidney Dis. 2015 Apr;65(4):632-4. doi: 10.1053/j.ajkd.2014.11.015. Epub 2015 Jan 22. No abstract available.

PMID:
25618185
47.

Podocyte Number in Children and Adults: Associations with Glomerular Size and Numbers of Other Glomerular Resident Cells.

Puelles VG, Douglas-Denton RN, Cullen-McEwen LA, Li J, Hughson MD, Hoy WE, Kerr PG, Bertram JF.

J Am Soc Nephrol. 2015 Sep;26(9):2277-88. doi: 10.1681/ASN.2014070641. Epub 2015 Jan 7.

48.

Kidney disease in Aboriginal Australians: a perspective from the Northern Territory.

Hoy WE.

Clin Kidney J. 2014 Dec;7(6):524-30. doi: 10.1093/ckj/sfu109. Epub 2014 Nov 13.

49.

Nephron hypertrophy and glomerulosclerosis in normal donor kidneys.

Hoy WE, Bertram JF, Hughson MD.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1832-4. doi: 10.2215/CJN.08680814. Epub 2014 Oct 15. No abstract available.

50.

Lifetime risk of hospital diagnosed chronic obstructive pulmonary disease in remote Aboriginal people: a cohort study.

Wang Z, Hoy WE.

Aust N Z J Public Health. 2014 Aug;38(4):340-3. doi: 10.1111/1753-6405.12233.

PMID:
25091073

Supplemental Content

Support Center